Panic disorder: Clinical phenomena and treatment options
Сиволап Y. П.
Журнал неврологии и психиатрии им. C.C. Корсакова
Т. 117, Вып. 4, С. 112-116
Опубликовано: 2017
Тип ресурса: Обзор
DOI:10.17116/jnevro20171174112-116
Аннотация:
Panic disorder is a common mental disease with high psychiatric comorbidity. It is considered that a combination of genetic predisposition and a special psychic vulnerability plays a key role in the occurrence of panic disorder. Clinically proven efficacy in the treatment of panic disorder have benzodiazepines, tricyclic antidepressants, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors and selective serotonin and norepinephrine reuptake inhibitors; antidepressants from other pharmaceutical groups are also used. Selective serotonin reuptake inhibitors are the first line medicines in the treatment of panic disorder. Atypical antipsychotics may be used for the therapy augmentation in addition to first line drugs. Psychotherapy is used along with medications, and a combination of pharmacotherapy and cognitive behavioral therapy is the best method of treatment. © 2017, Media Sphera Publishing Group. All right reserved.
Ключевые слова:
Agoraphobia; Benzodiazepines; Cognitive-behavioral therapy; Depression; Monoamine oxidase inhibitors; Panic attack; Panic disorder; Selective serotonin and norepinephrine reuptake inhibitors; Selective serotonin reuptake inhibitors; Tricyclic antidepressants
antidepressant agent; benzodiazepine derivative; monoamine oxidase inhibitor; noradrenalin uptake inhibitor; serotonin uptake inhibitor; antidepressant agent; serotonin uptake inhibitor; tricyclic antidepressant agent; cognitive behavioral therapy; comorbidity; genetic predisposition; panic; Review; human; panic; Antidepressive Agents; Antidepressive Agents, Tricyclic; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Serotonin Uptake Inhibitors
Язык текста: Русский
ISSN: 2309-4729
Сиволап Y. П.
Sivolap Y. P.
Panic disorder: Clinical phenomena and treatment options
Текст визуальный непосредственный
Журнал неврологии и психиатрии им. C.C. Корсакова
Издательство Медиа Сфера
Т. 117, Вып. 4 С. 112-116
2017
Обзор
Agoraphobia Benzodiazepines Cognitive-behavioral therapy Depression Monoamine oxidase inhibitors Panic attack Panic disorder Selective serotonin and norepinephrine reuptake inhibitors Selective serotonin reuptake inhibitors Tricyclic antidepressants
antidepressant agent benzodiazepine derivative monoamine oxidase inhibitor noradrenalin uptake inhibitor serotonin uptake inhibitor antidepressant agent serotonin uptake inhibitor tricyclic antidepressant agent cognitive behavioral therapy comorbidity genetic predisposition panic Review human panic Antidepressive Agents Antidepressive Agents, Tricyclic Humans Monoamine Oxidase Inhibitors Panic Disorder Serotonin Uptake Inhibitors
Panic disorder is a common mental disease with high psychiatric comorbidity. It is considered that a combination of genetic predisposition and a special psychic vulnerability plays a key role in the occurrence of panic disorder. Clinically proven efficacy in the treatment of panic disorder have benzodiazepines, tricyclic antidepressants, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors and selective serotonin and norepinephrine reuptake inhibitors; antidepressants from other pharmaceutical groups are also used. Selective serotonin reuptake inhibitors are the first line medicines in the treatment of panic disorder. Atypical antipsychotics may be used for the therapy augmentation in addition to first line drugs. Psychotherapy is used along with medications, and a combination of pharmacotherapy and cognitive behavioral therapy is the best method of treatment. © 2017, Media Sphera Publishing Group. All right reserved.